Tel. +39 010.51862.1



Tyrosine metabolism in health and disease

Phenylalanine (Phe) hydroxylase (PAH) deficiency leads to hyperphenylalaninemia (HPA) and tyrosine (Tyr) depletion. The study investigates Tyr homeostasis in patients with PAH deficiency and the effect of a slow-release amino acids therapy in phenylketonuria (PKU). Four complementary investigations were performed: (1) Tyr concentrations were monitored in 114 patients (10.6 ± 11.9 years) with PKU on...
Read More

Piam participates in CPhI 2019

Frankfurt 5-7 November: Piam is attending CPhI Worldwide for the fourth consecutive year. The event brings together over 45,000 senior pharmaceutical professionals, and 2,500 exhibitors from 150 countries...
Read More

PIAM takes part in the X National Congress SIMMESN 2019

Turin, 22-25 October 2019 PIAM takes part in the X National Congress SIMMESN (Italian Society for the Study of Inherited Metabolic Diseases and Newborn Screening), organizing a specific session, focused on slow-release protein substitutes of the Afenil line.
Read More

Piam participates in SSIEM 2019

PIAM, Italian leader in the dietary management of PKU and other IEM, is participating in SSIEM 2019, 2-6 September, Rotterdam. If you wish to contact us, please visit our stand E1.10
Read More

PIAM participates in CPhI Worldwide 2019

Frankfurt 5-7 November 2019: PIAM participates in CPhI Worldwide, visit us at stand 9.1 B32.
Read More

PIAM participates in Vitafoods Europe 2019

Geneva 7-9 May 2019: PIAM participates in Vitafoods Europe, visit us at our booth Q155.
Read More